ENOV - Enovis Corp logo

Enovis Corp

ENOV

Enovis Corporation develops medical technology solutions for musculoskeletal health, joint reconstruction, and pain management. It offers orthopedic bracing, surgical implants, and rehabilitation products, serving healthcare professionals and patients globally.

βš•οΈ Healthcare NYSE Listed 2008 $ USD
$1,000 invested 10 years ago β†’$418today

Score Overview

1 Year
Score
Net Growth6.99%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth2.16%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score3.4
Net Growth-15x
Net Trend20%
Net Income Consistencyβ€”
Rev Growth61.03%
Rev TrendEvery year
Revenue Consistencyβ€”
10 Years
Score
Net Growth-8x
Net Trend40%
Net Income Consistency
Rev Growth-37.03%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-1927x
Net Trend39%
Net Income Consistency
Rev Growth279.70%
Rev Trend61%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Enovis Corp has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • ENOV

2019: 39.8% Β· 2021: 65.7% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 21.59β€”
1 Year2025-10-22
$ 32.74-34.06%
5 Years2021-10-22
$ 88.21-75.52%
10 Years2016-10-21
$ 51.67-58.22%
All Time2008-05-08
$ 36.14-40.27%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 2.29B-$ 1.10B$ 12M
2025$ 2.24B-$ 1.18B$ 36M
2024$ 2.10B-$ 825M$ 48M
2023$ 1.70B-$ 33M$ 36M
2022$ 1.56B-$ 13M$ 24M
2021$ 1.42B$ 71M$ 680M
2020$ 3.07B$ 42M$ 101M
2019$ 3.32B-$ 527M$ 109M
2018$ 2.19B$ 140M$ 245M
2017$ 3.30B$ 151M$ 411M
2016$ 3.64B$ 128M$ 221M
2015$ 3.96B$ 167M$ 197M
2014$ 4.62B$ 392M$ 305M
2013$ 4.20B$ 178M$ 311M
2012$ 3.91B-$ 64M$ 482M
2011$ 693M$ 4M$ 75M
2010$ 541M$ 16M$ 60M
2009$ 525M$ 21M$ 49M
IPO2008$ 604M-$ 571K$ 28M
ENOV - Enovis Corp logo

Enovis Corp fundamental performance

Between 2020 and 2025, revenue declined from $ 3.07B to $ 2.24B and net income went from $ 42M to -$ 1.18B. Revenue increased in every one of those 5 years; net income in 1.

Across Enovis Corp's full reported history, from 2008 to 2025, revenue grew from $ 604M to $ 2.24B and net income went from -$ 571K to -$ 1.18B. Revenue increased in 61% of the years measured; net income in 39%.

Enovis Corp currently holds a 5-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.

Membership

Continue ENOV’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies